Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (511-520 of 568) with videos related to

Pageof 57
Sort By:
The ISME Journal|March 2, 2021
Genomic network analysis of environmental and livestock F-type plasmid populationsWilliam Matlock, Kevin K Chau, Manal AbuOun, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Covert dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC) in a successfully controlled outbreak: long- and short-read whole-genome sequencing demonstrate multiple genetic modes of transmissionJessica Martin, Hang T T Phan, Jacqueline Findlay, et al.
The Lancet. Infectious Diseases|August 22, 2018
Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health recordsKarina-Doris Vihta, Nicole Stoesser, Martin J Llewelyn, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
The Lancet. Microbe|April 4, 2022
The 2021 WHO catalogue of <i>Mycobacterium tuberculosis</i> complex mutations associated with drug resistance: A genotypic analysisTimothy M Walker, Paolo Miotto, Claudio U Köser, et al.
Plos Medicine|December 5, 2018
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trialCissy Kityo, Alexander J Szubert, Abraham Siika, et al.
The New England Journal of Medicine|July 12, 2014
Assessment of second-line antiretroviral regimens for HIV therapy in AfricaNicholas I Paton, Cissy Kityo, Anne Hoppe, et al.
Trials|October 22, 2021
A lived experience co-designed study protocol for a randomised control trial: the Attempted Suicide Short Intervention Program (ASSIP) or Brief Cognitive Behavioural Therapy as additional interventions after a suicide attempt compared to a standard Suicide Prevention Pathway (SPP)Nicolas J C Stapelberg, Candice Bowman, Sabine Woerwag-Mehta, et al.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
The New England Journal of Medicine|October 4, 2018
A Candida auris Outbreak and Its Control in an Intensive Care SettingDavid W Eyre, Anna E Sheppard, Hilary Madder, et al.
Pageof 57

Showing results (511-520 of 568) with videos related to

Sort By:
Pageof 57
The ISME Journal|March 2, 2021
Genomic network analysis of environmental and livestock F-type plasmid populationsWilliam Matlock, Kevin K Chau, Manal AbuOun, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Covert dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC) in a successfully controlled outbreak: long- and short-read whole-genome sequencing demonstrate multiple genetic modes of transmissionJessica Martin, Hang T T Phan, Jacqueline Findlay, et al.
The Lancet. Infectious Diseases|August 22, 2018
Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health recordsKarina-Doris Vihta, Nicole Stoesser, Martin J Llewelyn, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
The Lancet. Microbe|April 4, 2022
The 2021 WHO catalogue of <i>Mycobacterium tuberculosis</i> complex mutations associated with drug resistance: A genotypic analysisTimothy M Walker, Paolo Miotto, Claudio U Köser, et al.
Plos Medicine|December 5, 2018
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trialCissy Kityo, Alexander J Szubert, Abraham Siika, et al.
The New England Journal of Medicine|July 12, 2014
Assessment of second-line antiretroviral regimens for HIV therapy in AfricaNicholas I Paton, Cissy Kityo, Anne Hoppe, et al.
Trials|October 22, 2021
A lived experience co-designed study protocol for a randomised control trial: the Attempted Suicide Short Intervention Program (ASSIP) or Brief Cognitive Behavioural Therapy as additional interventions after a suicide attempt compared to a standard Suicide Prevention Pathway (SPP)Nicolas J C Stapelberg, Candice Bowman, Sabine Woerwag-Mehta, et al.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
The New England Journal of Medicine|October 4, 2018
A Candida auris Outbreak and Its Control in an Intensive Care SettingDavid W Eyre, Anna E Sheppard, Hilary Madder, et al.
Pageof 57